| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,344 | 3,490 | 1,532 | 2,719 | | Cost of Revenue | 3,901 | 4,205 | 2,332 | 3,968 | | | Gross Profit | (557) | (715) | (800) | (1,249) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,818 | 1,935 | 2,079 | 2,277 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,375) | (2,650) | (2,879) | (3,526) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29 | 503 | 213 | (473) | | Earnings Before Interest And Taxes | (2,164) | (2,147) | (2,666) | (3,999) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,164) | (2,147) | (2,666) | (3,999) | | Income Tax Expense | (844) | (707) | (897) | (1,265) | | Minority Interest | 254 | (106) | 106 | 204 | | | | Net Income From Continuing Ops | (1,597) | (1,654) | (1,737) | (2,333) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,343) | (1,654) | (1,737) | (2,333) | | Preferred Stock And Other Adjustments | (210) | 210 |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,553) | ($1,444) | ($1,737) | ($2,333) |
|
0.51% Nasdaq 
Income Statement
